CD5 CAR-T cells

CD5-targeted chimeric antigen receptor T cells · Zhejiang University

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CD5 CAR-T cells, covering 2024-10-09 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies [Phase 1, Phase 2]

See pricing